Skip to main content
Back to News
Basecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a st...
Technology
1 min read

Basecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a st...

The AMW Read

The launch of GPT-4 scale models specifically for programmable gene insertion represents a significant advancement in the 'Bio-platform bull' debate, moving vertical AI from simple documentation/ops into high-value predictive engineering.
NoveltySignificance
Healthcare & Bio · Player Map
Basecamp Research
Basecamp Research

AI in Biotech / Drug Discovery

View Company Profile

Basecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a strategic investment from Nvidia NVentures. Developed with Microsoft and Nvidia, these GPT-4 scale models successfully designed active proteins for 100 percent of tested disease target sites. By enabling large-scale DNA insertions beyond the reach of CRISPR, this platform shifts genetic medicine from trial-and-error to predictive, software-driven engineering. 🧬💻

#AI #Biotech #Nvidia #Genomics #Innovation

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1d agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  2. 4d agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  3. 4d agoGenBio AI, a Palo Alto-based AI company co-founded by Nobel laureate David Baker, has released AIDO...GenBio AI
  4. 7mo agoBasecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a st... · THIS ARTICLE

More news from Basecamp Research

Stay updated with the latest news and announcements from Basecamp Research.

View all Basecamp Research news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard